The Corona-Killing Bullet?

Maybe, but don't break out the champagne flutes yet.

Pfizer announces that its new antiviral pill cuts down the risk of hospitalization and death by almost 90 percent.

An experimental coronavirus pill reduced the risk of hospitalization and death by 89 percent in high-risk people infected with the virus, pharmaceutical giant Pfizer announced Friday.

The effect of the drug, a five-day regimen designed to block the virus from making copies of itself, was found to be so strong midway through the study that an independent committee monitoring the clinical trial recommended it be stopped early. The data has not yet been published or peer-reviewed. Pfizer chief executive Albert Bourla told CNBC that the company would submit data to U.S. regulators before Thanksgiving.

* * *

 David Boulware, an infectious-disease physician-scientist at the University of Minnesota Medical School not involved in the research said the findings were “pretty impressive.” He noted the drug was most effective when given earlier, within three days of symptoms, but it remained highly effective even when given five days after symptoms appeared — which may better reflect the real world use of the drug.

“That’s great. That’s a huge impact,” Boulware said.

Two dampeners:

1. As mentioned in the article, peer-review is necessary.

2. As a gent who got a suddenly-necessary Pfizer booster two weeks ago yesterday, understand that I am not inclined to pop corks for Pfizer's more grandiose claims. 

IF it is true, this is great and glorious news--a literal game-changing life-saver.

If so, it will turn corona into something more akin to the flu. Not to mention taking the steam out of the boiler of our society-straining vaccine wars. 

But let's wait and see.